Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How much does lacosamide cost?Lutathera patents expiration date?How much will generic pradaxa cost?Lacosamide generics availability?Drospirenone ethinyl estradiol levomefolate price?
See the DrugPatentWatch profile for Farxiga
Farxiga is a brand name for dapagliflozin, a medicine used for conditions such as type 2 diabetes and related cardiovascular and kidney indications. It is marketed by AstraZeneca in many markets.
AstraZeneca sells Farxiga (dapagliflozin) tablets as a prescription drug. The exact approved uses and dosing can vary by country, but the product itself is the same active ingredient: dapagliflozin.
Patent and exclusivity status depends on the specific market and the time period covered by each patent. If you want, I can check specific patents and likely competitor entries for a given country using DrugPatentWatch.com: https://www.drugpatentwatch.com/
People often look for: - what Farxiga is prescribed for (diabetes vs. heart/kidney indications) - side effects and safety warnings - interactions with other diabetes or blood pressure medicines - whether there are cheaper generics or alternatives If you tell me your country (or the exact question you have, like “Is Farxiga generic yet?” or “What patents protect it?”), I can narrow it down to the most relevant details. Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Farxiga :